N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia
Clinical trial NCT01885338 · COMPLETED
Trial details
- NCT number
- NCT01885338
- Sponsor
- VA Greater Los Angeles Healthcare System
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-05-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.